Number of typhoid fever cases in India in 2023, Pg12

Key Highlights:

• In 2023, India recorded 49 lakh cases of typhoid fever.
• Delhi, Maharashtra, and Karnataka accounted for approximately 30% of the national typhoid burden.
• Out of 7.3 lakh hospitalizations, 6 lakh were due to fluoroquinolone-resistance.
• The findings were published in The Lancet Regional Health Southeast Asia.

Detailed Insights:

• Typhoid fever remains a significant public health challenge in India, despite advancements in sanitation and healthcare.
• The high percentage of fluoroquinolone-resistance indicates a growing concern of antimicrobial resistance (AMR) in treating typhoid.
• Regional disparities highlight the need for targeted interventions in states like Delhi, Maharashtra, and Karnataka.
• Antimicrobial resistance increases treatment costs, hospitalization duration, and mortality rates associated with typhoid fever.

Key Concepts Involved:

• Typhoid Fever: A bacterial infection caused by Salmonella Typhi, typically spread through contaminated food and water.
• Antimicrobial Resistance (AMR): The ability of microorganisms to resist the effects of antimicrobial drugs, making infections harder to treat.
• Fluoroquinolone: A class of antibiotics commonly used to treat bacterial infections, including typhoid fever.